Genedrive Diagnostics Ltd

Currently there are limited Point-of-Care (PoC)-applicable sample processing methods needed to recover infectious disease targets from clinical samples prior to molecular diagnostic testing. This means analysis is restricted to centralised laboratory facilities and this significantly impacts time to result and subsequent treatment, and cost to the healthc...

Disease associated with White Spot Syndrome Virus (WSSV) and Early Mortality Synrdome (EMS) together cause over $3bn annual losses to the global farmed shrimp industry. Current losses from these pathogens alone far exceed all shrimp products imported to the EU each year. Accurate detection and management of disease is central to poverty alleviation in pro...

To provide the contract research division with a novel, commercially relevant model of EGFR inhibitor-induced human skin rash.

In vitro product testing is a vital part of product development for topical applications and devices and this project seeks to establish a powerful non-animal approach as a new method for providing a greater understanding of percutaneous absorption of topical formulations in pre-clinical studies. This project aims to develop label free imaging of drugs by...

Epistem, a UK company with expertise in delivering dermatological testing services and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biomass, aims to develop a new in vitro human living skin equivalent model for testing inflammatory responses. This is a novel method that will add to the field of dermatol...

To optimise, validate and commercialise new pre-clinical assays for cutaneous wound repair which will result in a new contract research service offering.